Tvardi Therapeutics, Inc. · Brief

Next report

9 days

Nov 12 · after closeest.Q3 FY26

Expected move

No implied move.

8 reportsHistory

1 of 4≥ implied

Mar 4 '24—▼−8.98%—

May 13 '24—▼−3.56%—

May 13 '25±0.4%▼−0.72%×1.70

Aug 14 '25—▲+0.88%—

Q3 FY25±28.3%▼−1.95%×0.07

Q1 FY26±68.8%▼−5.66%×0.08

May 8 '26—▼−0.71%—

Q2 FY26±67.0%▲+7.34%×0.11

quarterimplied−70%0+70%realized×

Q2 FY26±67.0%▲+7.34%×0.11

May '26—▼−0.71%—

Q1 FY26±68.8%▼−5.66%×0.08

Q3 FY25±28.3%▼−1.95%×0.07

Aug '25—▲+0.88%—

May '25±0.4%▼−0.72%×1.70

2 older reports

May '24—▼−3.56%—

Mar '24—▼−8.98%—

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Nov 12 report · est.

Bull1

56managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2 of 4

3of tracked funds holding TVRDN-PORT · Jun 30 '26

8 of 17of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26

AI captions · Sep 27 '26once per report · top 2 per case

TVRD report session

No linked exposure.

No changes.

privateThesis 0 · Decisions 0 · Observations 0

No thesis.